What may be in short supply when a safe, effective Coronavirus vaccine is available? The medical glass needed to produce vials to hold the vaccine. With plans to produce more than a billion doses globally, Johnson & Johnson bought 250 million vials in the U.S. at the start of the pandemic. Corning recently signed a $200+ million deal with the U.S. government to expand manufacturing capacity to meet demand.